3-(ethyl[(9h-fluoren-9-ylmethoxy)carbonyl]amino)propanoic acid, 95%, 5g

2-(4-Bromophenyl)oxazole, 95.0%, 25g

1-(4-Fluorobenzyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

1,7-Dihydro-dipyrrolo[2,3-b:3',2'-e]pyridine, 98%, 100mg

3-Methyl-2-cyclohexen-1-one>98.0%(GC)5g

Puntas dispensadoras Ritips® evolución estándar, 0,2 ml, 4-20 µl, 100 piezas

2,3-Difluoro-4-bromonitrobenzene, 95.0%, 25g

(2E)-3-(furan-2-yl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

Thalidomide-propargyl, 10mg

4-quinoxalin-2-ylphenol, 97%, 1g

3,5-Difluoro-4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenol, 97.0%, 250mg

(3S,4S)-1-(TERT-BUTOXYCARBONYL)-4-METHYLPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 5g

3-[2-Hydroxy-5-(methylthio)phenyl]propanoic acid, 95%, 100mg